Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
54.31
+0.08 (0.15%)
At close: Nov 21, 2025, 4:00 PM EST
54.84
+0.53 (0.98%)
After-hours: Nov 21, 2025, 7:57 PM EST
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $4.47 billion as of November 21, 2025. Its market cap has increased by 82.53% in one year.
Market Cap
4.47B
Enterprise Value
3.48B
1-Year Change
82.53%
Ranking
Category
Stock Price
$54.31
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $4.47B, an increase of 802.39%. That is a compound annual growth rate of 40.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 4.47B | 130.25% |
| Dec 31, 2024 | 1.94B | 49.28% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.29% |
| Dec 31, 2021 | 737.89M | -17.63% |
| Dec 31, 2020 | 895.82M | 41.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |